Moll Law Group Investigates Filing First Nationwide Class Action Lawsuit Against Testosterone Manufacturers

CHICAGO--()--Moll Law Group is investigating filing the first nationwide class action lawsuit against the makers of testosterone as a result of serious injuries and deaths linked to the products.

Users prescribed with low testosterone or “Low T” therapy are claiming testosterone is to blame for dangerous side effects such as:

  • stroke;
  • heart attack;
  • blood clots;
  • deep vein thrombosis; and
  • pulmonary embolism

leading to serious injuries and death.

The suit would claim that manufacturers knew of these risks and failed to warn the public. It would also claim that manufacturers aggressively marketed testosterone by misleading potential users about the safety and efficacy of low testosterone treatments; ultimately failing to protect users from serious, life-threatening, adverse medical events.

Recent studies indicate that men over 65 have a double risk of a heart attack within 90 days of starting hormone therapy. Among men under the age of 65 with a history of heart disease, there is a two-to-three fold increased risk of heart attack. Another study was discontinued due to a high rate of heart attacks. Learn more at http://www.molllawgroup.com/cases/testosterone.

In June, 2014, the U.S. Food and Drug Administration stated that testosterone products can cause dangerous blood clots in the legs and lungs and required drug makers to warn of the risks on testosterone product labels.

Testosterone is often administered as a gel, patch, or injection and may include the following products: Androderm (Watson Laboratories), Androgel (Abbott Laboratories and Abbvie, Inc.), Axiron (Eli Lilly and Company), Fortesta (Endo Pharmaceuticals), Striant (Auxilium), Testim (Prasco), Testoderm (Ferring Pharmaceuticals), Testopel (Auxilium), and Vogelxo (Upsher-Laboratories)

The Low Testosterone Therapy litigation will seek compensation for those who have died and been injured as a result of their use of testosterone and also seek to establish a medical monitoring fund for those that seek testing.

If you have a low testosterone therapy case and would like a prompt and confidential evaluation from a Moll Law Group lawyer, please complete our free online consultation form at http://www.molllawgroup.com or contact us at 312.462.1700.

Moll Law Group is a nationally recognized law firm concentrating in products liability and protecting the rights of consumers by providing safety information through its Legal News Network at http://www.legalnewsnetwork.com.

Contacts

Moll Law Group, Ltd., Chicago, IL USA
Ken Moll, 312.462.1700
kmoll@molllawgroup.com

Release Summary

Moll Law Group investigating filing first nationwide class action lawsuit against makers of testosterone for users who suffered stroke, heart attack, deep vein thrombosis and pulmonary embolism.

Sharing

Contacts

Moll Law Group, Ltd., Chicago, IL USA
Ken Moll, 312.462.1700
kmoll@molllawgroup.com